{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:13:38Z","timestamp":1786979618434,"version":"build-2736575974"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22006084"],"award-info":[{"award-number":["22006084"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Development Planning Project of Qingdao (Shinan District), China","award":["2022-2-004-YY"],"award-info":[{"award-number":["2022-2-004-YY"]}]},{"name":"Clinical Medicine + X Research Project of the Affiliated Hospital of Qingdao University","award":["X202101027"],"award-info":[{"award-number":["X202101027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00109-025-02540-1","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T05:39:08Z","timestamp":1744263548000},"page":"619-633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A comprehensive review of m6 A methylation in coronary heart disease"],"prefix":"10.1007","volume":"103","author":[{"given":"Mei-Ning","family":"Diao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jv","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2457-7712","authenticated-orcid":false,"given":"Yin-Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"issue":"25","key":"2540_CR1","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1016\/j.jacc.2020.11.021","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Fuster V (2020) The global burden of cardiovascular diseases and risks: a compass for global action. J Am Coll Cardiol 76(25):2980\u20132981","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"2540_CR2","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685\u20131695","journal-title":"N Engl J Med"},{"issue":"10","key":"2540_CR3","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.jacc.2003.12.047","volume":"43","author":"JA Ambrose","year":"2004","unstructured":"Ambrose JA, Barua RS (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43(10):1731\u20131737","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2540_CR4","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1161\/CIRCRESAHA.119.316065","volume":"126","author":"MO Goodarzi","year":"2020","unstructured":"Goodarzi MO, Rotter JI (2020) Genetics insights in the relationship between type 2 diabetes and coronary heart disease. Circ Res 126(11):1526\u20131548","journal-title":"Circ Res"},{"issue":"21","key":"2540_CR5","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","volume":"53","author":"CJ Lavie","year":"2009","unstructured":"Lavie CJ, Milani RV, Ventura HO (2009) Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53(21):1925\u20131932","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2540_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1055\/s-2002-36765","volume":"2","author":"CM Lawes","year":"2002","unstructured":"Lawes CM et al (2002) Blood pressure and coronary heart disease: a review of the evidence. Semin Vasc Med 2(4):355\u2013368","journal-title":"Semin Vasc Med"},{"key":"2540_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.pmedr.2016.06.006","volume":"4","author":"R Shimizu","year":"2016","unstructured":"Shimizu R et al (2016) Comparison of serum lipid management between elderly and non-elderly patients with and without coronary heart disease (CHD). Prev Med Rep 4:192\u2013198","journal-title":"Prev Med Rep"},{"issue":"6","key":"2540_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11886-019-1130-z","volume":"21","author":"M Sharifi","year":"2019","unstructured":"Sharifi M et al (2019) Polygenic hypercholesterolemia and cardiovascular disease risk. Curr Cardiol Rep 21(6):43","journal-title":"Curr Cardiol Rep"},{"issue":"2","key":"2540_CR9","doi-asserted-by":"publisher","first-page":"H189","DOI":"10.1152\/ajpheart.00087.2018","volume":"315","author":"AJ Cocciolone","year":"2018","unstructured":"Cocciolone AJ et al (2018) Elastin, arterial mechanics, and cardiovascular disease. Am J Physiol Heart Circ Physiol 315(2):H189-h205","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"2540_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOH.0000000000000688","volume":"29","author":"I Cobo","year":"2022","unstructured":"Cobo I et al (2022) Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease. Curr Opin Hematol 29(1):1\u20137","journal-title":"Curr Opin Hematol"},{"issue":"10","key":"2540_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11886-016-0777-y","volume":"18","author":"M Pjanic","year":"2016","unstructured":"Pjanic M et al (2016) Genetics and genomics of coronary artery disease. Curr Cardiol Rep 18(10):102","journal-title":"Curr Cardiol Rep"},{"issue":"10","key":"2540_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR (2019) Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol 20(10):608\u2013624","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"2540_CR13","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang X et al (2015) N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell 161(6):1388\u20131399","journal-title":"Cell"},{"issue":"7481","key":"2540_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X et al (2014) N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505(7481):117\u2013120","journal-title":"Nature"},{"issue":"1","key":"2540_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng G et al (2013) ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell 49(1):18\u201329","journal-title":"Mol Cell"},{"issue":"7","key":"2540_CR16","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer KD et al (2012) Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2019 UTRs and near stop codons. Cell 149(7):1635\u20131646","journal-title":"Cell"},{"issue":"33","key":"2540_CR17","doi-asserted-by":"publisher","first-page":"20117","DOI":"10.1016\/S0021-9258(17)30477-5","volume":"265","author":"T Csepany","year":"1990","unstructured":"Csepany T et al (1990) Sequence specificity of mRNA N6-adenosine methyltransferase. J Biol Chem 265(33):20117\u201320122","journal-title":"J Biol Chem"},{"issue":"20","key":"2540_CR18","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1093\/bioinformatics\/btac601","volume":"38","author":"Z Guo","year":"2022","unstructured":"Guo Z et al (2022) Differential RNA methylation analysis for MeRIP-seq data under general experimental design. Bioinformatics 38(20):4705\u20134712","journal-title":"Bioinformatics"},{"issue":"5","key":"2540_CR19","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/anie.201410647","volume":"54","author":"K Chen","year":"2015","unstructured":"Chen K et al (2015) High-resolution N(6) -methyladenosine (m(6) A) map using photo-crosslinking-assisted m(6) A sequencing. Angew Chem Int Ed Engl 54(5):1587\u20131590","journal-title":"Angew Chem Int Ed Engl"},{"issue":"8","key":"2540_CR20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nmeth.3453","volume":"12","author":"B Linder","year":"2015","unstructured":"Linder B et al (2015) Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat Methods 12(8):767\u2013772","journal-title":"Nat Methods"},{"key":"2540_CR21","doi-asserted-by":"publisher","first-page":"1392159","DOI":"10.3389\/fcell.2024.1392159","volume":"12","author":"Y Yang","year":"2024","unstructured":"Yang Y et al (2024) Current progress in strategies to profile transcriptomic m(6)A modifications. Front Cell Dev Biol 12:1392159","journal-title":"Front Cell Dev Biol"},{"key":"2540_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2022.123754","volume":"252","author":"Q Pu","year":"2023","unstructured":"Pu Q et al (2023) XNA probe and CRISPR\/Cas12a-powered flexible fluorescent and electrochemical dual-mode biosensor for sensitive detection of m6A site-specific RNA modification. Talanta 252:123754","journal-title":"Talanta"},{"issue":"4","key":"2540_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41587-023-01831-7","volume":"42","author":"Y Li","year":"2024","unstructured":"Li Y et al (2024) Single-cell m(6)A mapping in vivo using picoMeRIP-seq. Nat Biotechnol 42(4):591\u2013596","journal-title":"Nat Biotechnol"},{"issue":"1 Pt 1","key":"2540_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ygeno.2020.12.027","volume":"113","author":"S Das Mandal","year":"2021","unstructured":"Das Mandal S, Ray PS (2021) Transcriptome-wide analysis reveals spatial correlation between N6-methyladenosine and binding sites of microRNAs and RNA-binding proteins. Genomics 113(1 Pt 1):205\u2013216","journal-title":"Genomics"},{"issue":"1","key":"2540_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X et al (2021) The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther 6(1):74","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2540_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","volume":"12","author":"S Ma","year":"2019","unstructured":"Ma S et al (2019) The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol 12(1):121","journal-title":"J Hematol Oncol"},{"key":"2540_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108613","volume":"112","author":"T Sun","year":"2019","unstructured":"Sun T, Wu R, Ming L (2019) The role of m6A RNA methylation in cancer. Biomed Pharmacother 112:108613","journal-title":"Biomed Pharmacother"},{"key":"2540_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.659628","volume":"8","author":"D Song","year":"2021","unstructured":"Song D et al (2021) Role of N(6)-methyladenosine RNA modification in cardiovascular disease. Front Cardiovasc Med 8:659628","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2540_CR29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41467-023-35958-7","volume":"14","author":"H Yao","year":"2023","unstructured":"Yao H et al (2023) scm(6)A-seq reveals single-cell landscapes of the dynamic m(6)A during oocyte maturation and early embryonic development. Nat Commun 14(1):315","journal-title":"Nat Commun"},{"issue":"4","key":"2540_CR30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","volume":"118","author":"MA Gimbrone Jr","year":"2016","unstructured":"Gimbrone MA Jr, Garc\u00eda-Carde\u00f1a G (2016) Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res 118(4):620\u201336","journal-title":"Circ Res"},{"key":"2540_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.731810","volume":"9","author":"G Dong","year":"2021","unstructured":"Dong G et al (2021) N6-methyladenosine methyltransferase METTL3 promotes angiogenesis and atherosclerosis by upregulating the JAK2\/STAT3 pathway via m6A reader IGF2BP1. Front Cell Dev Biol 9:731810","journal-title":"Front Cell Dev Biol"},{"issue":"41","key":"2540_CR32","doi-asserted-by":"publisher","first-page":"10990","DOI":"10.1073\/pnas.1707517114","volume":"114","author":"NE Ajami","year":"2017","unstructured":"Ajami NE et al (2017) Systems biology analysis of longitudinal functional response of endothelial cells to shear stress. Proc Natl Acad Sci U S A 114(41):10990\u201310995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2540_CR33","doi-asserted-by":"crossref","unstructured":"Chien, C.S., et al., METTL3-dependent N(6)-methyladenosine RNA modification mediates the atherogenic inflammatory cascades in vascular endothelium. Proc Natl Acad Sci U S A, 2021. 118(7).","DOI":"10.1073\/pnas.2025070118"},{"key":"2540_CR34","doi-asserted-by":"crossref","unstructured":"Li, B., et al., RNA N(6)-methyladenosine modulates endothelial atherogenic responses to disturbed flow in mice. Elife, 2022. 11.","DOI":"10.7554\/eLife.69906"},{"issue":"20","key":"2540_CR35","doi-asserted-by":"publisher","first-page":"8939","DOI":"10.7150\/thno.45178","volume":"10","author":"D Jian","year":"2020","unstructured":"Jian D et al (2020) METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications. Theranostics 10(20):8939\u20138956","journal-title":"Theranostics"},{"issue":"5","key":"2540_CR36","doi-asserted-by":"publisher","first-page":"11832","DOI":"10.1080\/21655979.2022.2031409","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y et al (2022) Methyltransferase-like 14 silencing relieves the development of atherosclerosis via m(6)A modification of p65 mRNA. Bioengineered 13(5):11832\u201311843","journal-title":"Bioengineered"},{"issue":"12","key":"2540_CR37","first-page":"7015","volume":"24","author":"BY Zhang","year":"2020","unstructured":"Zhang BY et al (2020) METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion. Eur Rev Med Pharmacol Sci 24(12):7015\u20137023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2540_CR38","doi-asserted-by":"crossref","unstructured":"Rong, J., Y. Jie, and H. Zhao, m6A 'writer' KIAA1429 regulates the proliferation and migration of endothelial cells in atherosclerosis. Mol Biotechnol, 2022: p. 1\u20139.","DOI":"10.21203\/rs.3.rs-1959422\/v1"},{"issue":"1","key":"2540_CR39","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1515\/med-2022-0484","volume":"17","author":"X Zhang","year":"2022","unstructured":"Zhang X et al (2022) ALKBH5 inhibits TNF-\u03b1-induced apoptosis of HUVECs through Bcl-2 pathway. Open Med (Wars) 17(1):1092\u20131099","journal-title":"Open Med (Wars)"},{"issue":"11","key":"2540_CR40","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00109-021-02109-8","volume":"99","author":"YX Liu","year":"2021","unstructured":"Liu YX et al (2021) Lipid accumulation and novel insight into vascular smooth muscle cells in atherosclerosis. J Mol Med (Berl) 99(11):1511\u20131526","journal-title":"J Mol Med (Berl)"},{"key":"2540_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.913039","volume":"9","author":"Y Zhao","year":"2022","unstructured":"Zhao Y et al (2022) Methyltransferase like 3-mediated N6-methylatidin methylation inhibits vascular smooth muscle cells phenotype switching via promoting phosphatidylinositol 3-kinase mRNA decay. Front Cardiovasc Med 9:913039","journal-title":"Front Cardiovasc Med"},{"key":"2540_CR42","doi-asserted-by":"crossref","unstructured":"Chen, J., et al., Silencing METTL3 stabilizes atherosclerotic plaques by regulating the phenotypic transformation of vascular smooth muscle cells via the miR-375\u20133p\/PDK1 axis. Cardiovasc Drugs Ther, 2022.","DOI":"10.1007\/s10557-022-07348-6"},{"key":"2540_CR43","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbrc.2022.10.032","volume":"635","author":"L Zheng","year":"2022","unstructured":"Zheng L et al (2022) RNA-m6A modification of HDGF mediated by Mettl3 aggravates the progression of atherosclerosis by regulating macrophages polarization via energy metabolism reprogramming. Biochem Biophys Res Commun 635:120\u2013127","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2540_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24019","volume":"36","author":"Z Li","year":"2022","unstructured":"Li Z et al (2022) Mettl3 promotes oxLDL-mediated inflammation through activating STAT1 signaling. J Clin Lab Anal 36(1):e24019","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"2540_CR45","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00018-022-04331-0","volume":"79","author":"Y Zheng","year":"2022","unstructured":"Zheng Y et al (2022) Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-\u03baB\/IL-6 signaling pathway. Cell Mol Life Sci 79(6):311","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"2540_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101058","volume":"297","author":"X Zhang","year":"2021","unstructured":"Zhang X et al (2021) The m(6)A methyltransferase METTL3 modifies PGC-1\u03b1 mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes. J Biol Chem 297(3):101058","journal-title":"J Biol Chem"},{"key":"2540_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.817304","volume":"8","author":"R Kumari","year":"2021","unstructured":"Kumari R et al (2021) ALKBH5 regulates SPHK1-dependent endothelial cell angiogenesis following ischemic stress. Front Cardiovasc Med 8:817304","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"2540_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.402","volume":"11","author":"Y Zhao","year":"2021","unstructured":"Zhao Y et al (2021) Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A. Clin Transl Med 11(5):e402","journal-title":"Clin Transl Med"},{"key":"2540_CR49","doi-asserted-by":"crossref","unstructured":"van den Homberg, D.A.L., et al., N-6-methyladenosine in vasoactive microRNAs during hypoxia; a novel role for METTL4. Int J Mol Sci, 2022. 23(3).","DOI":"10.3390\/ijms23031057"},{"issue":"8","key":"2540_CR50","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1080\/15548627.2019.1586246","volume":"15","author":"H Song","year":"2019","unstructured":"Song H et al (2019) METTL3 and ALKBH5 oppositely regulate m(6)A modification of TFEB mRNA, which dictates the fate of hypoxia\/reoxygenation-treated cardiomyocytes. Autophagy 15(8):1419\u20131437","journal-title":"Autophagy"},{"issue":"6","key":"2540_CR51","doi-asserted-by":"publisher","first-page":"H1553","DOI":"10.1152\/ajpheart.00158.2018","volume":"315","author":"S Toldo","year":"2018","unstructured":"Toldo S et al (2018) Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 315(6):H1553-h1568","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2540_CR52","doi-asserted-by":"crossref","unstructured":"Wang, X., et al., Mechanism of METTL3-mediated m(6)A modification in cardiomyocyte pyroptosis and myocardial ischemia-reperfusion injury. Cardiovasc Drugs Ther, 2022.","DOI":"10.1007\/s10557-021-07300-0"},{"issue":"8","key":"2540_CR53","doi-asserted-by":"publisher","first-page":"11135","DOI":"10.18632\/aging.202770","volume":"13","author":"J Wang","year":"2021","unstructured":"Wang J et al (2021) WTAP promotes myocardial ischemia\/reperfusion injury by increasing endoplasmic reticulum stress via regulating m(6)A modification of ATF4 mRNA. Aging (Albany NY) 13(8):11135\u201311149","journal-title":"Aging (Albany NY)"},{"key":"2540_CR54","doi-asserted-by":"crossref","unstructured":"Wang, H., et al., m6A methyltransferase WTAP regulates myocardial ischemia reperfusion injury through YTHDF1\/FOXO3a signaling. Apoptosis, 2023.","DOI":"10.1007\/s10495-023-01818-4"},{"key":"2540_CR55","doi-asserted-by":"crossref","unstructured":"Pang, P., et al., YTHDF2 promotes cardiac ferroptosis via degradation of SLC7A11 in cardiac ischemia-reperfusion injury. Antioxid Redox Signal, 2023.","DOI":"10.1089\/ars.2023.0291"},{"key":"2540_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.762853","volume":"9","author":"P Pang","year":"2021","unstructured":"Pang P et al (2021) Mettl14 attenuates cardiac ischemia\/reperfusion injury by regulating wnt1\/\u03b2-catenin signaling pathway. Front Cell Dev Biol 9:762853","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2540_CR57","doi-asserted-by":"publisher","first-page":"6762","DOI":"10.1038\/s41467-022-34434-y","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L et al (2022) METTL14 is required for exercise-induced cardiac hypertrophy and protects against myocardial ischemia-reperfusion injury. Nat Commun 13(1):6762","journal-title":"Nat Commun"},{"issue":"7","key":"2540_CR58","doi-asserted-by":"publisher","first-page":"417","DOI":"10.21037\/atm-22-1289","volume":"10","author":"J Li","year":"2022","unstructured":"Li J et al (2022) Downregulated ALKBH5 contributes to myocardial ischemia\/reperfusion injury by increasing m(6)A modification of Trio mRNA. Ann Transl Med 10(7):417","journal-title":"Ann Transl Med"},{"key":"2540_CR59","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15269","volume":"11","author":"L Liu","year":"2023","unstructured":"Liu L, Liu Z (2023) m(6)A eraser ALKBH5 mitigates the apoptosis of cardiomyocytes in ischemia reperfusion injury through m(6)A\/SIRT1 axis. PeerJ 11:e15269","journal-title":"PeerJ"},{"issue":"3","key":"2540_CR60","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1080\/21655979.2022.2030572","volume":"13","author":"WL Ke","year":"2022","unstructured":"Ke WL et al (2022) m(6)A demethylase FTO regulates the apoptosis and inflammation of cardiomyocytes via YAP1 in ischemia-reperfusion injury. Bioengineered 13(3):5443\u20135452","journal-title":"Bioengineered"},{"issue":"12","key":"2540_CR61","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1113\/EP089901","volume":"106","author":"W Deng","year":"2021","unstructured":"Deng W, Jin Q, Li L (2021) Protective mechanism of demethylase fat mass and obesity-associated protein in energy metabolism disorder of hypoxia-reoxygenation-induced cardiomyocytes. Exp Physiol 106(12):2423\u20132433","journal-title":"Exp Physiol"},{"issue":"5","key":"2540_CR62","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s11010-021-04069-6","volume":"476","author":"W Shen","year":"2021","unstructured":"Shen W et al (2021) FTO overexpression inhibits apoptosis of hypoxia\/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt. Mol Cell Biochem 476(5):2171\u20132179","journal-title":"Mol Cell Biochem"},{"key":"2540_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2019.109451","volume":"135","author":"R Saxena","year":"2020","unstructured":"Saxena R, Weintraub NL, Tang Y (2020) Optimizing cardiac ischemic preconditioning and postconditioning via epitranscriptional regulation. Med Hypotheses 135:109451","journal-title":"Med Hypotheses"},{"issue":"12","key":"2540_CR64","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1093\/abbs\/gmaa130","volume":"52","author":"Y Su","year":"2020","unstructured":"Su Y et al (2020) N6-methyladenosine methyltransferase plays a role in hypoxic preconditioning partially through the interaction with lncRNA H19. Acta Biochim Biophys Sin (Shanghai) 52(12):1306\u20131315","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"1","key":"2540_CR65","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","volume":"7","author":"Q Zhang","year":"2022","unstructured":"Zhang Q et al (2022) Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther 7(1):78","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"2540_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.779","volume":"12","author":"P Sun","year":"2022","unstructured":"Sun P et al (2022) Extracellular vesicle-packaged mitochondrial disturbing miRNA exacerbates cardiac injury during acute myocardial infarction. Clin Transl Med 12(4):e779","journal-title":"Clin Transl Med"},{"key":"2540_CR67","doi-asserted-by":"crossref","unstructured":"Tang, J., Q.X. Tang, and S. Liu, METTL3-modified lncRNA-SNHG8 binds to PTBP1 to regulate ALAS2 expression to increase oxidative stress and promote myocardial infarction. Mol Cell Biochem, 2022.","DOI":"10.1007\/s11010-022-04570-6"},{"key":"2540_CR68","doi-asserted-by":"crossref","unstructured":"Li, D., et al., ALKBH5 regulates N(6)-methyladenosine (m6A) methylation of MG53 to attenuate myocardial infarction by inhibiting apoptosis and oxidative stress. J Cardiovasc Pharmacol, 2023.","DOI":"10.1097\/FJC.0000000000001515"},{"key":"2540_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105845","volume":"174","author":"R Gong","year":"2021","unstructured":"Gong R et al (2021) Loss of m(6)A methyltransferase METTL3 promotes heart regeneration and repair after myocardial injury. Pharmacol Res 174:105845","journal-title":"Pharmacol Res"},{"key":"2540_CR70","doi-asserted-by":"crossref","unstructured":"Jiang, F.Q., et al., Mettl3-mediated m(6)A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration. Elife, 2022. 11.","DOI":"10.7554\/eLife.77014"},{"issue":"1","key":"2540_CR71","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41420-023-01457-3","volume":"9","author":"S Li","year":"2023","unstructured":"Li S et al (2023) IGF2BP3 promotes adult myocardial regeneration by stabilizing MMP3 mRNA through interaction with m6A modification. Cell Death Discov 9(1):164","journal-title":"Cell Death Discov"},{"issue":"6","key":"2540_CR72","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.7150\/thno.47354","volume":"11","author":"Z Han","year":"2021","unstructured":"Han Z et al (2021) ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1. Theranostics 11(6):3000\u20133016","journal-title":"Theranostics"},{"key":"2540_CR73","doi-asserted-by":"crossref","unstructured":"Yang, K., et al., ALKBH5 induces fibroblast-to-myofibroblast transformation during hypoxia to protect against cardiac rupture after myocardial infarction. J Adv Res, 2023.","DOI":"10.2139\/ssrn.4376158"},{"issue":"2","key":"2540_CR74","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201903169R","volume":"35","author":"T Li","year":"2021","unstructured":"Li T et al (2021) Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts. Faseb j 35(2):e21162","journal-title":"Faseb j"},{"issue":"3","key":"2540_CR75","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201734R","volume":"37","author":"Y Zhuang","year":"2023","unstructured":"Zhuang Y et al (2023) MetBil as a novel molecular regulator in ischemia-induced cardiac fibrosis via METTL3-mediated m6A modification. Faseb j 37(3):e22797","journal-title":"Faseb j"},{"key":"2540_CR76","doi-asserted-by":"crossref","unstructured":"Cheng, H., et al., TNC accelerates hypoxia-induced cardiac injury in a METTL3-dependent manner. Genes (Basel), 2023. 14(3).","DOI":"10.3390\/genes14030591"},{"issue":"4","key":"2540_CR77","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/jcmm.17183","volume":"26","author":"L Qi","year":"2022","unstructured":"Qi L et al (2022) New insights into the central sympathetic hyperactivity post-myocardial infarction: roles of METTL3-mediated m(6) A methylation. J Cell Mol Med 26(4):1264\u20131280","journal-title":"J Cell Mol Med"},{"key":"2540_CR78","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.yjmcc.2022.06.004","volume":"170","author":"L Qi","year":"2022","unstructured":"Qi L et al (2022) m(6)A methyltransferase METTL3 participated in sympathetic neural remodeling post-MI via the TRAF6\/NF-\u03baB pathway and ROS production. J Mol Cell Cardiol 170:87\u201399","journal-title":"J Mol Cell Cardiol"},{"issue":"Pt 2","key":"2540_CR79","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.freeradbiomed.2023.10.392","volume":"209","author":"P Yang","year":"2023","unstructured":"Yang P et al (2023) m6A methyltransferase METTL3 contributes to sympathetic hyperactivity post-MI via promoting TRAF6-dependent mitochondrial ROS production. Free Radic Biol Med 209(Pt 2):342\u2013354","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"2540_CR80","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s12012-024-09898-7","volume":"24","author":"Y Liu","year":"2024","unstructured":"Liu Y et al (2024) Role of M6a methylation in myocardial ischemia-reperfusion injury and doxorubicin-induced cardiotoxicity. Cardiovasc Toxicol 24(9):918\u2013928","journal-title":"Cardiovasc Toxicol"},{"key":"2540_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.113969","volume":"197","author":"JS Chang","year":"2021","unstructured":"Chang JS et al (2021) Ultra performance liquid chromatography-tandem mass spectrometry assay for the quantification of RNA and DNA methylation. J Pharm Biomed Anal 197:113969","journal-title":"J Pharm Biomed Anal"},{"key":"2540_CR82","doi-asserted-by":"publisher","first-page":"1167132","DOI":"10.3389\/fcvm.2023.1167132","volume":"10","author":"F Guo","year":"2023","unstructured":"Guo F et al (2023) Levels and clinical significance of the m6A methyltransferase METTL14 in patients with coronary heart disease. Front Cardiovasc Med 10:1167132","journal-title":"Front Cardiovasc Med"},{"key":"2540_CR83","doi-asserted-by":"publisher","first-page":"1185873","DOI":"10.3389\/fcvm.2023.1185873","volume":"10","author":"Y Jiang","year":"2023","unstructured":"Jiang Y et al (2023) Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of coronary heart disease using the Gene Expression Omnibus database. Front Cardiovasc Med 10:1185873","journal-title":"Front Cardiovasc Med"},{"key":"2540_CR84","doi-asserted-by":"publisher","first-page":"2877679","DOI":"10.1155\/2022\/2877679","volume":"2022","author":"Y Pan","year":"2022","unstructured":"Pan Y et al (2022) Identification and validation of immune markers in coronary heart disease. Comput Math Methods Med 2022:2877679","journal-title":"Comput Math Methods Med"},{"issue":"5","key":"2540_CR85","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.21037\/jtd-22-569","volume":"14","author":"C Liang","year":"2022","unstructured":"Liang C et al (2022) Diagnosis, clustering, and immune cell infiltration analysis of m6A-related genes in patients with acute myocardial infarction-a bioinformatics analysis. J Thorac Dis 14(5):1607\u20131619","journal-title":"J Thorac Dis"},{"key":"2540_CR86","doi-asserted-by":"publisher","first-page":"5173761","DOI":"10.1155\/2022\/5173761","volume":"2022","author":"X Wang","year":"2022","unstructured":"Wang X et al (2022) Comprehensive analysis of N6-methyladenosine RNA methylation regulators in the diagnosis and subtype classification of acute myocardial infarction. J Immunol Res 2022:5173761","journal-title":"J Immunol Res"},{"issue":"2","key":"2540_CR87","doi-asserted-by":"publisher","first-page":"219","DOI":"10.7150\/ijms.86210","volume":"21","author":"S Zhu","year":"2024","unstructured":"Zhu S et al (2024) Integrative Analysis of N6-methyladenosine RNA modifications related genes and their Influences on Immunoreaction or fibrosis in myocardial infarction. Int J Med Sci 21(2):219\u2013233","journal-title":"Int J Med Sci"},{"issue":"10","key":"2540_CR88","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2217\/epi-2018-0007","volume":"10","author":"XB Mo","year":"2018","unstructured":"Mo XB et al (2018) Detection of m(6)A-associated SNPs as potential functional variants for coronary artery disease. Epigenomics 10(10):1279\u20131287","journal-title":"Epigenomics"},{"key":"2540_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.836067","volume":"9","author":"X Tong","year":"2022","unstructured":"Tong X et al (2022) Predicting diagnostic gene biomarkers associated with immune checkpoints, N6-methyladenosine, and ferroptosis in patients with acute myocardial infarction. Front Cardiovasc Med 9:836067","journal-title":"Front Cardiovasc Med"},{"key":"2540_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175761","volume":"951","author":"Y Fu","year":"2023","unstructured":"Fu Y et al (2023) Detailed profiling of m6A modified circRNAs and synergistic effects of circRNA and environmental risk factors for coronary artery disease. Eur J Pharmacol 951:175761","journal-title":"Eur J Pharmacol"},{"key":"2540_CR91","doi-asserted-by":"publisher","first-page":"1016081","DOI":"10.3389\/fcvm.2022.1016081","volume":"9","author":"Z Liu","year":"2022","unstructured":"Liu Z et al (2022) Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction. Front Cardiovasc Med 9:1016081","journal-title":"Front Cardiovasc Med"},{"key":"2540_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109176","volume":"245","author":"Z Sun","year":"2022","unstructured":"Sun Z et al (2022) Matr3 reshapes m6A modification complex to alleviate macrophage inflammation during atherosclerosis. Clin Immunol 245:109176","journal-title":"Clin Immunol"},{"key":"2540_CR93","doi-asserted-by":"crossref","unstructured":"Wang, L., et al., Maslinic acid suppresses high glucose-induced inflammation by epigenetically inhibiting TXNIP expression. Curr Med Sci, 2022.","DOI":"10.1007\/s11596-022-2657-6"},{"key":"2540_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.861734","volume":"13","author":"W Zhu","year":"2022","unstructured":"Zhu W, Zhang H, Wang S (2022) Vitamin D3 suppresses human cytomegalovirus-induced vascular endothelial apoptosis via rectification of paradoxical m6A modification of mitochondrial calcium uniporter mRNA, which is regulated by METTL3 and YTHDF3. Front Microbiol 13:861734","journal-title":"Front Microbiol"},{"issue":"2","key":"2540_CR95","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00011-021-01533-3","volume":"71","author":"YB Huo","year":"2022","unstructured":"Huo YB et al (2022) Dihydroartemisinin alleviates AngII-induced vascular smooth muscle cell proliferation and inflammatory response by blocking the FTO\/NR4A3 axis. Inflamm Res 71(2):243\u2013253","journal-title":"Inflamm Res"},{"key":"2540_CR96","doi-asserted-by":"crossref","unstructured":"Cui, J.K., et al., Curcuminoids attenuate myocardial ischemia-reperfusion injury by regulating total RNA m6A levels: in vitro study. Comb chem high throughput screen, 2022.","DOI":"10.2174\/1386207325666220929141003"},{"key":"2540_CR97","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.actbio.2021.11.041","volume":"140","author":"P Cheng","year":"2022","unstructured":"Cheng P et al (2022) Amelioration of acute myocardial infarction injury through targeted ferritin nanocages loaded with an ALKBH5 inhibitor. Acta Biomater 140:481\u2013491","journal-title":"Acta Biomater"},{"issue":"1","key":"2540_CR98","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13020-023-00736-6","volume":"18","author":"Y Li","year":"2023","unstructured":"Li Y et al (2023) Suxiao Jiuxin pill alleviates myocardial ischemia-reperfusion injury through the ALKBH5\/GSK3\u03b2\/mTOR pathway. Chin Med 18(1):31","journal-title":"Chin Med"},{"issue":"12","key":"2540_CR99","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301292R","volume":"37","author":"X Gao","year":"2023","unstructured":"Gao X et al (2023) Downregulation of ALKBH5 rejuvenates aged human mesenchymal stem cells and enhances their therapeutic efficacy in myocardial infarction. Faseb j 37(12):e23294","journal-title":"Faseb j"},{"issue":"40","key":"2540_CR100","doi-asserted-by":"publisher","first-page":"46583","DOI":"10.1021\/acsami.3c06318","volume":"15","author":"B Huang","year":"2023","unstructured":"Huang B et al (2023) Programmed release METTL3-14 inhibitor microneedle protects myocardial function by reducing Drp1 m6A modification-mediated mitochondrial fission. ACS Appl Mater Interfaces 15(40):46583\u201346597","journal-title":"ACS Appl Mater Interfaces"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02540-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T03:02:36Z","timestamp":1749092556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02540-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2540"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02540-1","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics approval was required for this review that did not involve patients or patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}